January 11, 2021

Sanofi makes a pre-JP Morgan splash with Kymab

The Kymab takeover represents another bold move as the French company bids to rebuild its pipeline.

February 28, 2019

Go or no go? Johnson & Johnson awaits Spravato nod

Others hoping to get FDA approvals include Sage Therapeutics and Novartis, but hopes look dimmer for Lexicon and Sanofi.

December 17, 2018

Lilly buys into ion channels – again

December 15, 2016

Eucrisa thumbs up validates Pfizer’s takeover strategy – partly

September 02, 2016

Behold the son of Blincyto

July 16, 2013

Early-stage asset risk no deterent to partnering deals

January 02, 2013

Pharma regulatory news over the Christmas period

December 09, 2011

Pharmacyclics strikes most lucrative single-product deal of 2011

August 03, 2011

Diverging average upfront trend suggests logic returning to deal terms